Clinical Trial Update: Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating prophylactic octreotide to prevent bleeding after duodenal EMR and ampullectomy; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoma

Drugs mentioned

• OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: AdventHealth | Conditions: Adenoma | Phase 4 | Status: TERMINATED